Most not too long ago, it has been discovered that conolidine and the above mentioned derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in similar areas as classical opioid receptors, it binds to a big selection of endogenous opioids. In contrast to most opioid receptors, this receptor https://brianl478sqn0.worldblogged.com/profile